Showing posts with label milk powder. Show all posts
Showing posts with label milk powder. Show all posts

Saturday, 2 August 2014

INFANT FORMULA SAFETY: FAO/WHO: Carrageenan Safe in Infant Formula

FAO/WHO: Carrageenan Safe in Infant Formula
 - Blog
Print



At its 79th meeting in June, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) completed an in-depth review of the science related to the safety of carrageenan and found it safe for use in infant formula, including formula for special medical purposes.

After reviewing available research on carrageenan safety, particularly a new study of piglets that is representative of human infants consuming carrageenan in infant formula, JECFA concluded that “the use of carrageenan in infant formula or formula for special medical purposes at concentrations up to 1000 mg/L is not of concern."

The safety of carrageenan—a soluble fiber made from red seaweed and used as a stabilizer in food—has been a topic of much debate. In 2012, FDA rejected a petition filed by Joanne Tobacman, Ph.D., a physician-scientist at the University of Illinois College of Medicine, asking the agency to revoke regulation permitting the use of carrageenan as a food additive. Tobacman claimed carrageenan and its breakdown product created dangerous inflammation.

The ingredient stirred so much commotion that some manufacturers removed or pledged to remove it from their organic products, particularly within the dairy foods/drinks segment.

And the controversy hasn’t blown over yet—at least, not completely. According to information in the March issue of the Boardroom Journal, “Navigating Consumer Activism," carrageenan is one of several ingredients on consumers’ social media “hit lists," meaning it’s been picking up negative buzz across various social media platforms. Other ingredients to make the hit list include high-fructose corn syrup, brominated vegetable oil and MSG, among others.

Some critics of carrageenan have cited scientific findings in regulatory comments or in social media that refer to animal testing using poligeenan, a substance sometimes improperly referred to as “degraded carrageenan" that is never used in foods. However, research has shown that food grade carrageenan is safe and binds so tightly to protein that it cannot be broken down into poligeenan during digestion.

“The carrageenan we use today in food has undergone strenuous review by numerous regulatory agencies around the world and in every single case it has been declared safe," said Marinalg International President Bill Matakas. “Its unique abilities to stabilize food, to replace fat or to extend shelf life in certain uses make it an important asset in not just the enjoyment of food, but also in the effort to provide safe, affordable food—including infant formula—to all parts of the world."

As recently as 2013, U.S. regulatory agencies continued approval of carrageenan for use in organic infant formula and other organic foods.

JECFA is a scientific review panel that evaluates the safety of food additives. Its reports are used to guide food additive regulatory approvals around the world. Carrageenan was one of four food additives reviewed in 2014 for use in infant formula by a special JECFA committee.

Wednesday, 26 June 2013

Infant formula exports are booming

Infant formula exports booming


JUDITH GALTRY0

Columnists

Place for light rail to ease burdenCoalition options a pain for LabourNigella's trouble no 'playful tiff'Making the best of Basin optionsThe joys and sorrow of uncledomIT disasters a worry in face of IRD projectFluoride nutters bite off too muchDunne's a scalp that may weigh too heavyBigger Maori role in Antarctica urgedDevious election deals done cheap


OPINION: Infant formula is New Zealand's export superstar. However, does this trade undermine best health and nutrition practice globally and, if so, what can be done about it?
Ministry of Economic Development figures show that in 2009 formula exports were worth $753 million to the New Zealand economy, up from $63 million in 1999. Business commentators suggest formula export income may now be around $1 billion.
As one of the world's leading milk powder producers and exporters, New Zealand is benefiting from the expansion in large, emerging offshore infant formula markets, particularly in East Asia.
After the US, China is currently the largest infant formula market in the world - worth US$6 billion (NZ$7.43 billion) in 2011 - and is projected to double by 2016.
The phase-out of infant formula tariffs agreed to under the 2008 New Zealand-China Free Trade Agreement has helped New Zealand's infant formula export boom. New Zealand is currently the second largest offshore infant formula provider for the Chinese market (18 per cent share), after Singapore (37 per cent), and ahead of Australia (15 per cent).
Multimillion dollar processing plants (some part or wholly Chinese-owned) are springing up in New Zealand to manufacture formula for China's rapidly expanding market, where a can of formula (costing around $20 in New Zealand) can sell for over NZ$70 a can. Recent moves by New Zealand dairy exporters toward exporting "added value", pre-constituted formula (rather than raw milk powder) has led to these high price margins, with some calling it the new gold rush.
In New Zealand, the trend of buying large quantities of formula from supermarkets for illegal export to China has led to purchase restrictions in many retail outlets. In China, unethical marketing practices, including industry representatives approaching new mothers in hospitals with formula samples, exploit opportunities created by urbanisation, growth of the middle classes, increased maternal employment, higher disposable incomes and the one- child policy.
Middle-class Chinese parents, with just one child to invest in, are willing to pay premium prices for formula from safe suppliers. On top of that, following China's 2008 melamine infant feeding scandal, infant food safety fears have led to demand for products from perceived "high quality" sources such as New Zealand.
While the detrimental environmental effects of dairy industry expansion have been debated recently in New Zealand, the potential health effects of the infant formula trade have been largely overlooked.

In 2012, Unicef expressed concern about sharply declining breastfeeding rates, including exclusive breastfeeding of babies under six months, in East Asia, and about companies' marketing and lobbying tactics. The same year, Wikileaks exposed efforts by United States corporations to persuade Asian leaders to stop breastfeeding promotion. A 2013 report by Save the Children shows a fall in China's breastfeeding rates, including exclusive breastfeeding of infants under six months.
Not breastfeeding exclusively increases the risk of infant morbidity and mortality. This risk is greatly increased where there is poor water quality and sanitation and where parents are illiterate and unable to read formula preparation instructions.
Media reports have recently highlighted serious water pollution issues in China, while in 2012 Unicef reported good sanitation facilities were available to only 58 per cent and 52 per cent of China's urban and rural populations respectively.
Part of the global framework for protecting breastfeeding and babies fed on formula is the restrictions placed on infant formula marketing in the World Health Organisation's International Code of Marketing of Breastmilk Substitutes, 1981 (WHO Code). In China, several WHO Code principles are enacted in law, but there is reportedly little enforcement and few penalties for breaches, including for promoting formula for newborns and babies. A Save the Children survey in China found 40 per cent of mothers who were interviewed reported being contacted directly by formula companies. Most were recommended products or offered free samples.
New Zealand signed the WHO Code in 1983 and implements it under three voluntary and self- regulatory codes, along with the Australia New Zealand Food Standards Code. New Zealand's voluntary industry agreement applies to infant formula manufacture and importing within New Zealand, including restricting formula marketing for infants under six months. In Australia, industry-agreed marketing controls are stronger, applying to infants under 12 months.
Currently, industry standards for infant formula manufacture and marketing within New Zealand are stronger than those governing our exports. Export standards (under consideration) include some exemptions on formula composition and a blanket exemption for labelling, requiring only that these meet importing countries' requirements. Some New Zealand exporters targeting East Asian markets are promoting formula for babies.
There are now calls from within our dairy sector for "alignment" of New Zealand's infant formula standards. But given less consideration are the ethical and public health implications for New Zealand as a major infant formula producer and exporter. Despite debates about the adequacy of national efforts, we try to promote and support breastfeeding among our own population. By contrast, we are potentially undermining breastfeeding practice in China and other countries where we know breastfeeding protection is weaker.
So what could New Zealand do? While various international health and trade agreements for marketing infant formula exist, they depend on implementation and enforcement in individual countries. New Zealand and Australia, countries that are influential in China's babyfood market, could take a moral leadership role by requiring all their exporters to comply with the WHO Code or, at least, their own domestic industry agreements, so that standards for infant formula marketing both within and beyond Australasia are consistent.
As in industrialised countries, balancing good child health outcomes (including breastfeeding), maternal employment and gender equity will be complex in China. While New Zealand could show leadership in terms of the marketing of infant formula exports, much of the solution lies with China. This requires good maternity leave systems and WHO Code enforcement, along with other factors including implementation of WHO and Unicef's Baby Friendly Hospital Initiative.
The world media have already highlighted the environmental costs of dairying in New Zealand. This could be compounded by potential charges of unethical infant formula marketing. In the same way the industry is making some effort to solve its environmental issues, the export superstar could support "best practice" child health policy globally and not undermine it.
Dr Judith Galtry is an adjunct fellow at the Australian Centre for Economic Research on Health, Australian National University.